Financial results - DRUGE CRIS INTERPREST S.R.L.

Financial Summary - Druge Cris Interprest S.r.l.
Unique identification code: 35577924
Registration number: J29/227/2016
Nace: 4120
Sales - Ron
471.469
Net Profit - Ron
246.955
Employee
6
The most important financial indicators for the company Druge Cris Interprest S.r.l. - Unique Identification Number 35577924: sales in 2023 was 471.469 euro, registering a net profit of 246.955 euro and having an average number of 6 employees. Firma isi desfasoara activitatea in domeniul Lucrari de constructii a cladirilor rezidentiale si nerezidentiale having the NACE code 4120.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Druge Cris Interprest S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - 91.619 184.982 316.126 402.058 320.957 648.374 486.765 471.469
Total Income - EUR - - 91.631 190.855 316.175 402.104 321.043 658.482 487.764 472.109
Total Expenses - EUR - - 39.289 90.995 119.432 146.387 138.061 228.164 230.174 220.527
Gross Profit/Loss - EUR - - 52.342 99.859 196.743 255.717 182.982 430.318 257.590 251.582
Net Profit/Loss - EUR - - 51.350 97.651 193.581 251.696 179.772 423.733 252.713 246.955
Employees - - 12 0 4 8 19 6 5 6
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -2.8%, from 486.765 euro in the year 2022, to 471.469 euro in 2023. The Net Profit decreased by -4.991 euro, from 252.713 euro in 2022, to 246.955 in the last year.

Check the financial reports for the company - Druge Cris Interprest S.r.l.

Rating financiar

Financial Rating -
Druge Cris Interprest S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Druge Cris Interprest S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Druge Cris Interprest S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Druge Cris Interprest S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Druge Cris Interprest S.r.l. - CUI 35577924

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - 528 1.317 14.341 26.504 34.574 28.776 25.303 62.319
Current Assets - - 54.762 158.553 341.000 439.133 562.494 105.056 82.061 196.895
Inventories - - 0 0 0 0 0 5.075 0 4.468
Receivables - - 0 16.999 51.087 91.238 101.385 98.703 74.614 179.175
Cash - - 54.762 141.554 289.913 347.895 461.110 1.278 7.447 13.252
Shareholders Funds - - 51.395 150.314 341.137 436.622 564.703 56.280 -24.900 145.713
Social Capital - - 45 44 43 42 41 40 41 40
Debts - - 3.895 9.955 14.596 29.015 32.366 77.553 132.264 113.501
Income in Advance - - 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4120 - 4120"
CAEN Financial Year 4120
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 196.895 euro in 2023 which includes Inventories of 4.468 euro, Receivables of 179.175 euro and cash availability of 13.252 euro.
The company's Equity was valued at 145.713 euro, while total Liabilities amounted to 113.501 euro. Equity increased by 170.538 euro, from -24.900 euro in 2022, to 145.713 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Druge Cris Interprest S.r.l.

Comments - Druge Cris Interprest S.r.l.

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.